Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Quantitative assessment of the effects of MMP-2 polymorphisms on lung carcinoma risk.

Guo XT, Wang JF, Zhang LY, Xu GQ.

Asian Pac J Cancer Prev. 2012;13(6):2853-6.

2.

Matrix metalloproteinase 2 polymorphisms and expression in lung cancer: a meta-analysis.

Wang J, Cai Y.

Tumour Biol. 2012 Dec;33(6):1819-28. doi: 10.1007/s13277-012-0441-0. Epub 2012 Jun 21.

PMID:
22718017
3.

Quantitative assessment of the effect of MTHFR polymorphisms on the risk of lung carcinoma.

Zhang Y, Chen GQ, Ji Y, Huang B, Shen WS, Deng LC, Xi L, Cao XM.

Mol Biol Rep. 2012 May;39(5):6203-11. doi: 10.1007/s11033-011-1439-1. Epub 2012 Jan 4.

PMID:
22215214
4.

Is a single nucleotide polymorphism a risk factor for lung cancer in the matrix metalloproteinase-2 promoter?

Ayşegül B, Veysi GH, Muzaffer M, Irfan D, Azra A, Hulyam K.

Mol Biol Rep. 2011 Mar;38(3):1469-74. doi: 10.1007/s11033-010-0253-5. Epub 2010 Sep 16.

PMID:
20845079
5.

Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.

Hu C, Wang J, Xu Y, Li X, Chen H, Bunjhoo H, Xiong W, Xu Y, Zhao J.

Gene. 2013 Mar 15;517(1):65-71. doi: 10.1016/j.gene.2012.12.085. Epub 2013 Jan 9.

PMID:
23313298
6.

The MMP-1, MMP-2, and MMP-9 gene polymorphisms and susceptibility to bladder cancer: a meta-analysis.

Yan Y, Liang H, Li T, Li M, Li R, Qin X, Li S.

Tumour Biol. 2014 Apr;35(4):3047-52. doi: 10.1007/s13277-013-1395-6. Epub 2014 Jan 5.

7.

Comprehensive assessment of the association between DNA repair gene XRCC3 rs861539 C/T polymorphism and lung cancer risk.

Ding G, Xu W, Hua H, Huang Q, Liang H, Ni Y, Ding Z.

Tumour Biol. 2013 Oct;34(5):2521-7. doi: 10.1007/s13277-013-0705-3. Epub 2013 Aug 28.

PMID:
23982880
8.

Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk.

Zhang C, Li C, Zhu M, Zhang Q, Xie Z, Niu G, Song X, Jin L, Li G, Zheng H.

PLoS One. 2013 Apr 24;8(4):e62023. doi: 10.1371/journal.pone.0062023. Print 2013.

9.

Association between the XRCC3 C241T polymorphism and lung cancer risk in the Asian population.

Tian X, Tian Y, Ma P, Sui C, Meng F, Li Y, Fu L, Jiang T, Wang Y, Jiang Y.

Tumour Biol. 2013 Oct;34(5):2589-97. doi: 10.1007/s13277-013-0806-z. Epub 2013 Jun 8.

PMID:
23749486
10.

Effects of common polymorphism rs11614913 in Hsa-miR-196a2 on lung cancer risk.

Yuan Z, Zeng X, Yang D, Wang W, Liu Z.

PLoS One. 2013 Apr 12;8(4):e61047. doi: 10.1371/journal.pone.0061047. Print 2013.

11.

The relationship of metalloproteinase gene polymorphisms and lung cancer.

Sanli M, Akar E, Pehlivan S, Bakır K, Tuncozgur B, Isik AF, Pehlivan M, Elbeyli L.

J Surg Res. 2013 Aug;183(2):517-23. doi: 10.1016/j.jss.2013.01.045. Epub 2013 Feb 14.

PMID:
23465389
12.

Association of matrix metalloproteinase-9 C1562T polymorphism and coronary artery disease: a meta-analysis.

Wang X, Shi LZ.

J Zhejiang Univ Sci B. 2014 Mar;15(3):256-63. doi: 10.1631/jzus.B1300088. Review.

13.

Functional polymorphisms of matrix metalloproteinase-9 are associated with risk of occurrence and metastasis of lung cancer.

Hu Z, Huo X, Lu D, Qian J, Zhou J, Chen Y, Xu L, Ma H, Zhu J, Wei Q, Shen H.

Clin Cancer Res. 2005 Aug 1;11(15):5433-9.

14.

Lack of association between the matrix metalloproteinase-2 -1306C>T polymorphism and breast cancer susceptibility: a meta-analysis.

Yang L, Li N, Wang S, Kong Y, Tang H, Xie X, Xie X.

Asian Pac J Cancer Prev. 2014;15(12):4823-7.

15.
16.

Association between microsomal epoxide hydrolase 1 T113C polymorphism and susceptibility to lung cancer.

Wang S, Zhu J, Zhang R, Wang S, Gu Z.

Tumour Biol. 2013 Apr;34(2):1045-52. doi: 10.1007/s13277-012-0644-4. Epub 2013 Feb 3. Review.

PMID:
23378225
17.

Association between MPO 463G>A polymorphism and risk of lung cancer: a meta-analysis.

Zhou C, Luo Q, Qing Y, Lin X, Zhan Y, Ouyang M.

Tumour Biol. 2013 Dec;34(6):3449-55. doi: 10.1007/s13277-013-0921-x. Epub 2013 Aug 14.

PMID:
23943394
18.

Matrix metalloproteinase-9 -1562C/T promoter polymorphism confers risk for COPD: a meta-analysis.

Chen L, Wang T, Liu L, Shen Y, Wan C, Wen F.

PLoS One. 2013;8(3):e60523. doi: 10.1371/journal.pone.0060523. Epub 2013 Mar 28.

19.

APE1 Asp148Glu gene polymorphism and lung cancer risk: a meta-analysis.

Ji YN, Zhan P, Wang J, Qiu LX, Yu LK.

Mol Biol Rep. 2011 Oct;38(7):4537-43. doi: 10.1007/s11033-010-0584-2. Epub 2010 Dec 4.

PMID:
21132382
20.

Supplemental Content

Support Center